The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics
The three main types of live bacterial therapies – probiotics, fecal/microbiome transplants, and engineered bacterial therapies – hold immense potential to revolutionize medicine. While offering targeted and personalized treatments for various diseases, these therapies also carry risks such as adver...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2517377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|